Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of VIRX will decline by -21.27% over the next 2 Weeks and hit $0.01 by Thursday, October 2, 2025. In that time frame, VIRX's share price is expected to range between $0.01 and $0.01.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Oct 2, 2025 | 0.01 | 0.01 | 0.01 |
| Oct 1, 2025 | 0.00 | 0.01 | 0.01 |
| Sep 30, 2025 | 0.00 | 0.01 | 0.01 |
| Sep 29, 2025 | 0.00 | 0.01 | 0.01 |
| Sep 26, 2025 | 0.01 | 0.01 | 0.01 |
| Sep 25, 2025 | 0.01 | 0.01 | 0.01 |
| Sep 24, 2025 | 0.00 | 0.01 | 0.01 |
| Sep 23, 2025 | 0.00 | 0.01 | 0.01 |
| Sep 22, 2025 | 0.01 | 0.01 | 0.01 |
| Sep 19, 2025 | 0.01 | 0.01 | 0.01 |
VIRX shares remained flat 0 in Thursday, June 18, 2026's trading session, starting and closing at a previous close of $0.01 to move at $0.01. The stock demonstrated notable intraday movement (see VIRX's key stats for a full breakdown), fluctuating between $0.01 and $0.01, a 0 trading range. While recent weeks have seen some volatility, VIRX has managed to secure a 0 no change over the past 2 weeks. The neutral price movement was accompanied by remained steady trading volume, with approximately 0 shares changing hands, 0 fewer than the previous session. This amounted to $0.00 in total market activity.
Will VIRX Continue Its Upward Trend?
According to analyst ratings and projections for VIRX, Viracta Therapeutics, Inc. shares are anticipated to increase by +3.40%, potentially reaching $0.01 per share by October 2, 2025. Short-term technical indicators for VIRX currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 25 negative trading days within the past 30 sessions. Based on the VIRX stock forecast, now is a good time to buy VIRX stock because its current trading price is +27.01% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on VIRX covering social and institutional perspectives.
VIRX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into VIRX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 3.39% to 14.56%) suggest the stock is in a strong bearish momentum phase. The 50-day RSI, at 36.42%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 40.78%, maintains a neutral outlook for the long term. Insights into VIRX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Viracta Therapeutics, Inc. Monthly Forecast 2026
January 2026
According to our latest forecast models, Viracta Therapeutics, Inc. (VIRX) is positioned to show a strong performance in January 2026. The price is predicted to move between $0.00 and $0.07, settling at an average of $0.02. This could translate to a +104.50% gain.
February 2026
Based on current market signals, Viracta Therapeutics, Inc. is projected to trend february 2026. We forecast a trading range from $0.00 to $0.06, with a likely average price of $0.01. Investors could expect a potential return of +2.25%.
March 2026
Our predictive algorithms indicate Viracta Therapeutics, Inc. stock may see a shift in March 2026. The expected range spans $0.00–$0.06, with an average target of $0.01. This represents a positive outlook and a possible gain of +2.25%.
April 2026
Analyzing established trends, Viracta Therapeutics, Inc. looks set to move in April 2026. Projections place the stock between $0.00 and $0.06, averaging around $0.01. This suggests a +2.25% gain from current levels.
May 2026
Market indicators suggest Viracta Therapeutics, Inc. could experience notable changes during May 2026. Prices could fluctuate within $0.00 to $0.06, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
June 2026
Forecasting for June 2026, models estimate that Viracta Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.06, averaging $0.01. This signals a positive trajectory with potential returns around +2.25%.
July 2026
According to our latest forecast models, Viracta Therapeutics, Inc. (VIRX) is positioned to show a strong performance in July 2026. The price is predicted to move between $0.00 and $0.05, settling at an average of $0.00. This could translate to a -100.00% loss.
August 2026
Based on current market signals, Viracta Therapeutics, Inc. is projected to trend august 2026. We forecast a trading range from $0.00 to $0.05, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
September 2026
Our predictive algorithms indicate Viracta Therapeutics, Inc. stock may see a shift in September 2026. The expected range spans $0.00–$0.05, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
VIRX's history of dividends and stock splits also plays a role in long-term investor confidence.